Zhong-Chao Zhu

Zhong-Chao Zhu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
WHWei-Min Hu
Wei-Min Hu
SLSi-Qing Liu
Si-Qing Liu
KZKong-Fan Zhu
Kong-Fan Zhu
WLWei Li
Wei Li
ZYZhi-Jian Yang
Zhi-Jian Yang
JCJian Chang
Jian Chang

28 November 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
ZZZhengle Zhang
Zhengle Zhang
HHHan Han
Han Han
YRYuping Rong
Yuping Rong
KZKongfan Zhu
Kongfan Zhu
ZZZhong-Chao Zhu
Zhong-Chao Zhu
JTJing Tao
Jing Tao
Profound chemoresistance remains an intractable obstacle in pancreatic cancer treatment. Pancreatic cancer stem cells (CSCs) and the ubiquitous hypoxic niche have been proposed to account for drug resistance. However, the mechanism involved requires further exploration. This study investigated whether the hypoxic niche enhances gemcitabine-induced stemness and acquired resistance in pancreatic cancer cells by activating the AKT/Notch1 signaling cascade. The therapeutic effects of blockading this signaling cascade on gemcitabine-enriched CSCs were also investigated. The expression levels of CSC-associated markers Bmi1 and Sox2 as well as those of proteins involved in AKT/Notch1 signaling were measured by Western blot analysis. The expression level of the pancreatic CSC marker CD24 was measured by flow cytometry. Change in gemcitabine sensitivity was evaluated by the MTT assay. The ability of sphere formation was tested by the sphere-forming assay in stem cell medium. The ability of migration and invasion was detected by the transwell migration/invasion assay. A mouse xenograft model of pancreatic cancer was established to determine the effect of Notch1 inhibition on the killing effect of gemcitabine in vivo. The ability of metastasis was investigated by an in vivo lung metastasis assay. Gemcitabine promoted pancreatic cancer cell stemness and associated malignant phenotypes such as enhanced migration, invasion, metastasis, and chemoresistance. The AKT/Notch1 signaling cascade was activated after gemcitabine treatment and mediated this process. Blockading this pathway enhanced the killing effect of gemcitabine in vivo. However, supplementation with hypoxia treatment synergistically enhanced the AKT/Notch1 signaling pathway and collaboratively promoted gemcitabine-induced stemness. These findings demonstrate a novel mechanism of acquired gemcitabine resistance in pancreatic cancer cells through induction of stemness, which was mediated by the activation of AKT/Notch1 signaling and synergistically aggravated by the ubiquitous hypoxic niche. Our results might provide new insights for identifying potential targets for reversing chemoresistance in patients with pancreatic cancer.

2 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GQGong Qiong
Gong Qiong
ZZZhang Zhengle
Zhang Zhengle
HYHu Yiqian
Hu Yiqian
HXHuang Xu
Huang Xu
ZWZhou Wei
Zhou Wei
ZZZhong-Chao Zhu
Zhong-Chao Zhu
Periampullary diverticulum (PAD) often increases the difficulty of ERCP operation, and there is no standardized treatment strategy. This study compared the efficacy of “small incision + large balloon dilation (EST + EPBD)” with traditional ERCP. 111 patients with PAD complicated with choledocholithiasis were randomly divided into experimental group (n = 55, EST < 5 mm + EPBD) and control group (n = 56, conventional EST/EPBD). The primary endpoints were one-time stone clearance and adverse event rate, while secondary endpoints included operative time and common bile duct pressure. One-time stone clearance rate: test group 98.1% vs. control group 87.5% (P = 0.029) • Mean operation time: 24 ± 9 min vs. 31 ± 11 min (P < 0.001) • CBD pressure 6 days after surgery: 11.5 ± 2.3 vs. 8.5 ± 1.6 cm H₂O (P < 0.001) • Incidence of postoperative pancreatitis: 3.6% vs. 10.7% (P = 0.206). EST + EPBD can significantly improve stone removal efficiency, shorten operation time, and may improve long-term prognosis by preserving Oddi sphincter function.

19 July 2025 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
ZZZhengle Zhang
Zhengle Zhang
QGQiong Gong
Qiong Gong
QYQiang Yang
Qiang Yang
YRYuping Rong
Yuping Rong
JLJing Luo
Jing Luo
ZZZhong-Chao Zhu
Zhong-Chao Zhu

10 February 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KZKongfan Zhu
Kongfan Zhu
HHHua Hu
Hua Hu
ZYZhijian Yang
Zhijian Yang
ZZZhong-Chao Zhu
Zhong-Chao Zhu
Background: Pancreatitis-associated sepsis (PAS) caused by carbapenem-resistant bacteria poses significant clinical challenges. The objective of this research was to examine the microbial and metabolic profiles of individuals with carbapenem-resistant Acinetobacter baumannii (CRAB) and Escherichia coli (CREC) infections using integrated microbiomics and metabolomics approaches. Methods: Peripheral blood samples from 11 PAS patients (8 CRAB, 3 CREC) were analyzed using 16S rDNA gene sequencing and untargeted metabolomics via LC-MS. Microbial diversity, community structure, and differential metabolites were examined between CRAB and CREC groups. Results: CRAB patients exhibited higher microbial diversity compared to CREC patients. p- Proteobacteria , p- Firmicutes , and p- Cyanobacteria predominated in both patient groups. Significant differences in microbial composition were observed, with p- Proteobacteria more abundant in CRAB and p- Cyanobacteria in CREC samples. g- Enhydrobacter and s- Moraxella osloensis were the biomarkers, significantly higher in CREC patients. Metabolomic analysis revealed 328 differential metabolites between groups, with the majority being downregulated in CRAB. The main categories of identified differential metabolites were amino acids and their derivatives. These differential metabolites were closely related to various metabolic pathways. The most significant metabolic difference between the two patient groups was the level of triglycerides. R-2 Methanandamide and 13-(β-D-glucosyloxy) docosanoic acid showed the highest correlation with g- Enhydrobacter and s- Moraxella osloensis . Conclusion: In PAS patients, s- Moraxella osloensis is a biomarker distinguishing CRAB and CREC infections, correlating with R-2 Methanandamide and 13-(β-D-glucosyloxy) docosanoic acid.

11 August 2025 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
ZZZhengle Zhang
Zhengle Zhang
JTJing Tao
Jing Tao
ZZZhong-Chao Zhu
Zhong-Chao Zhu